Novavax bosses cash out for $46 mil with COVID-19 vaccine trials still under way
Novavax bosses cash out for $46 mil with COVID-19 vaccine trials still under way Jan. 16 05:01 am JST Feb. 11 | 12:40 am JST NEW YORK The requested article has expired, and is no longer available. Any related articles, and user comments are shown below. © Thomson Reuters 2021. ©2021 GPlusMedia Inc. Jan. 16 07:39 am JST Cashing out on a 34 year old company which has yet to bring a vaccine to market. Not very encouraging! 2 ( ...
Source: japantoday.com